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Abstract
Spirochetes causing Lyme borreliosis are obligate parasites that can only be found in a tick vector or a vertebrate host. The
ability to survive in these two disparate environments requires up and downregulation of specific genes by regulatory
circuits that remain largely obscure. In this work on the Lyme spirochete, B. burgdorferi, we show that a disruption of the
hrpA gene, which encodes a putative RNA helicase, results in a complete loss in the ability of the spirochetes to infect mice
by needle inoculation. Studies of protein expression in culture by 2D gels revealed a change in the expression of 33 proteins
in hrpA clones relative to the wild-type parent. Quantitative characterization of protein expression by iTRAQ analysis
revealed a total of 187 differentially regulated proteins in an hrpA background: 90 downregulated and 97 upregulated.
Forty-two of the 90 downregulated and 65 of the 97 upregulated proteins are not regulated under any conditions by the
previously reported regulators in B. burgdorferi (bosR, rrp2, rpoN, rpoS or rrp1). Downregulated and upregulated proteins also
fell into distinct functional categories. We conclude that HrpA is part of a new and distinct global regulatory pathway in B.
burgdorferi gene expression. Because an HrpA orthologue is present in many bacteria, its participation in global regulation
in B. burgdorferi may have relevance in other bacterial species where its function remains obscure. We believe this to be the
first report of a role for an RNA helicase in a global regulatory pathway in bacteria. This finding is particularly timely with the
recent growth of the field of RNA regulation of gene expression and the ability of RNA helicases to modulate RNA structure
and function.
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Introduction
Lyme borreliosis is common in the northern hemisphere and is
now the most frequent tick-borne disease in North America and
Europe [1,2]. The causative agents, Borrelia burgdorferi and related
species, are obligate parasites that survive through a complex
enzootic cycle involving a tick vector and a vertebrate host.
Differential gene regulation in these two environments is an
important feature for successful adaptation to both the tick vector
and the infected animal (see [3,4,5] for recent reviews). About 150
genes appear to be differentially regulated in B. burgdorferi,
depending upon environmental conditions and tick or host factors
required for survival in these very different settings [6,7,8,9,10,
11,12,13,14,15,16].
There is much that remains unknown about the regulatory
pathways in Borrelia species, which as in other organisms can
function at the transcriptional and translational stages and at steps
in between. Studies in B. burgdorferi are complicated by the need for
growth in ticks and animals to accurately characterize global gene
regulation. Nonetheless, several different regulatory molecules and
pathways that play a role in differential gene expression have been
identified, including the BosR regulator [5,14,15,16,17,18],
alternative s factors RpoS and RpoN [7,12,19,20] and the RpoN
activator Rrp2 [21,22,23]. The two-component response regula-
tory system Rrp1-Hpk1 [24] as well as the DNA binding and
bending protein Hbb [25], and DNA supercoiling [26,27] also
play a role in the modulation of gene expression in B. burgdorferi.
RNA regulation has also been recently reported in B. burgdorferi;
the RNA regulator DsrA has been shown to regulate the
expression of rpoS and ospC [28] and the RNA chaperone Hfq
appears to be involved in regulating the expression of pathoge-
nicity factors [29].
RNA helicases are important enzymes present in virtually all
living organisms. They unwind double stranded RNA in an
energy-dependent manner and are involved in a wide variety of
RNA metabolic functions [30,31,32,33]. HrpA, a DEAH-box
RNA helicase has been shown to be involved in processing of daa
mRNA from a fimbrial operon in E. coli. The processing event
results in a stable mRNA and upregulation of daa expression
relative to other proteins encoded by the polycistronic transcript
[34]. The HrpA protein also appears to be involved in physical
interactions with a variety of ribosomal proteins in E. coli, either
directly, or indirectly through RNA interaction [35], consistent
with a possible regulatory role at the translational level. Other
than these two reports, no other information on the function of
HrpA in any bacterium exists in the current literature.
As part of our ongoing work on antigenic variation in B.
burgdorferi, we generated a disruption of the hrpA (bb0827) gene,
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6which encodes a putative RNA helicase (Fig. 1), to see if loss of
this function would have an effect upon antigenic switching at the
vlsE locus. Surprisingly, the gene disruption resulted in a complete
loss of infectivity and the modulation of the expression of about
180 B. burgdorferi proteins. Our findings suggest that HrpA is
involved in a global regulatory pathway and may have relevance
to regulation of virulence in other pathogens and to global
regulatory mechanisms in bacteria in general.
Results
Construction of hrpA and bb0826 gene disruptions in B.
burgdorferi
Disruption of the hrpA (bb0827) gene in B. burgdorferi was
accomplished by allelic exchange [36]. A knockout plasmid
(Fig. 2A) was constructed in E. coli, in which the central 500 bp
of the hrpA gene was deleted and replaced with a gentamycin
resistance cassette (aacC1) under the control of the B. burgdorferi flgB
promoter. The orientation of the resistance cassette relative to the
target genes are shown in Table 1. A knockout plasmid was also
constructed for bb0826, the gene downstream from hrpA, which
contains an RNA binding motif and therefore, was considered as a
protein that might function together with HrpA. The constructs
were used to transform infectious B. burgdorferi B31 clone 5A4 [37].
The transformants recovered were screened by PCR as shown in
Fig. 2B (results for bb0826 not shown). First, the presence of the
gentamycin resistance cassette was verified (Panel 1, lanes 2–4),
followed by confirmation that the central 500 bp of the target gene
was no longer present (panel 2, lanes7–9). To confirm that the
recovered mutants carried only the disrupted hrpA gene and were
not merodiploids, the presence of only the disrupted gene carrying
the gent cassette (2.1 kb) was verified (Panel 3, lanes 12–14) along
with the absence of the wild-type gene (1.5 kb, lane 11). Finally,
the correct insertion site was confirmed using PCR primers to
uniquely amplify left and right side deletion junctions (Panel 4,
lanes 18–23). In addition, the structural integrity of the gene
disruptions and the presence of only a single disrupted gene were
independently demonstrated by Southern hybridization using
probes specific for the gentamycin cassette and the deleted portion
of the hrpA or bb0826 gene (see Fig. S1 for the Southern blot of the
hrpA gene disruption).
All genetic constructs were analyzed for plasmid content, which
can affect infectivity. No plasmid loss was observed for GCB1164
(hrpA2) and GCB1165 (hrpA3). GCB1166 (hrpA4) was lacking cp32-
3 and cp32-6; cp32-3 is not required for infectivity [37] and the
effect of loss of cp32-6 has not been previously reported. GCB543
(bb0826-3) and GCB544 (bb0826-11) both contained a full plasmid
complement. Finally, analysis of transcription of the downstream
genes bb0825 and bb0826 in the hrpA mutant strains was performed
by RT-PCR to determine whether the hrpA gene disruptions had a
polar effect and displayed reduced expression of the downstream
genes; no decrease in downstream gene expression was observed in
any of the three hrpA mutant clones (see Fig. S2). All three clones
displayed wild-type morphology and normal growth in BSK-II
media (data not shown).
Effect of hrpA and bb0826 gene disruptions on C3H/HeN
mouse infections
The mutant strains were each used to infect C3H/HeN mice
using an inoculum of 1610
3 spirochetes at two locations (see
Materials and Methods). At seven days post-infection spirochetes
were not recovered from the blood of any of the mice inoculated
with the hrpA mutant clones, in contrast to the bb0826 mutants and
the control group where all the cultures were positive for
spirochetes (Table 2). Similarly, ear cultures at day 21 were all
negative for the mice inoculated with hrpA mutant spirochetes, but
100% positive for the bb0826 mutants and the wild-type
spirochetes. Finally, at day 35 when all cultures from heart,
bladder, ear and joint were positive for wild-type and bb0826
mutant B. burgdorferi, no positive cultures were recovered from the
mice infected with the hrpA mutant clones. Mutation of the hrpA
gene, therefore, appeared to obliterate spirochete infectivity.
Attempts to complement the non-infectious phenotype by
supplying the hrpA gene in trans on the shuttle vector pBSV2
[38] were unsuccessful (data not shown). Difficulty in comple-
menting mutants in B. burgdorferi is not unusual and is elaborated
upon in the Discussion.
2D gel analysis of proteins from wild-type and hrpA
mutant B. burgdorferi
Because gene regulation by an RNA helicase is expected to
occur primarily at the post-transcriptional level, we compared the
protein content of wild-type B. burgdorferi B31 parent and their
derivative hrpA mutant strains. Whole cell lysates were prepared
from spirochetes grown to late log stage and were separated by
two-dimensional gel electrophoresis. Silver staining methods were
used to visualize proteins on the 2D gels. Approximately 600
protein spots were detected in the range of 10–80 kDa and the
pH 3–10 area. The 2D gel profiles of the three hrpA mutant clones
were indistinguishable from each other (data not shown). A
comparison of the wild-type 2D gel profile compared to the hrpA3
mutant (GCB1165) is shown in Fig. 3. In total, 33 protein spots
were identified with changes in intensity between wild-type B.
burgdorferi B31 and the hrpA mutant strains on silver stained
analytical gels. Twenty of the proteins were identified by LC-MS/
MS analysis of tryptic peptides coupled with a Mascot database
search (Table 3). For 13 spots, the identification was not
successful due to low MS signals or Mascot scores that were
below the threshold. Both identified and unidentified protein spots
are listed in decreasing order based upon their estimated fold
decrease or increase relative to wild-type (Table 3). Out of the 20
Figure 1. Schematic representation of conserved DEAH-box RNA helicase motifs in the B. burgdorferi HrpA protein. The sequence and
location of conserved motifs of the DEAH-box family aligned with B. burgdorferi HrpA are shown. Amino acids in the DEAH-box consensus that are
conserved at least 80% are shown in capital letters, and small letters represent the amino acids with 50–70% conservation. For further details
regarding the DEAH-box motifs see [31,32]. * denotes either T or S at three positions in the consensus sequence. The regions highlighted in yellow
are perfect matches between the B. burgdorferi HrpA protein and the consensus sequence and the numbers below the boxes represents the position
of the conserved motifs in HrpA.
doi:10.1371/journal.pone.0022168.g001
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PLoS ONE | www.plosone.org 2 July 2011 | Volume 6 | Issue 7 | e22168Figure 2. hrpA gene disruption and confirmation. A) Gene disruption strategy. The infectious B. burgdorferi strain B31, clone 5A4 (B31-5A4) was
transformed with a knockout plasmid carrying a 1 kb gentamicin cassette (blue) that replaced the central 500 bp of the hrpA gene (yellow) as
described in Materials and Methods. The two possible outcomes of recombination events with the target gene are shown: allelic exchange would
result in gene disruption while integrative recombination of the knockout plasmid would result in merodiploid formation. The position of PCR
primers used for construct verification are shown by arrows on the schematic. B) PCR verification of the hrpA disruption. Each gene disruption was
subjected to four PCR analyses. Panel 1) The presence of the gentamicin resistance cassette was confirmed as shown. The shuttle vector pBSV2G [38]
served as the positive control (c
+) for amplification of the gent cassette (lane 5). Panel 2) The portion of hrpA expected to be deleted in a gene
disruption was not detected in hrpA2, 3 or 4 (lanes 7, 8 and 9). Lane 10 was a negative control (c
2) that lacked DNA template. Panel 3) The size of the
hrpA gene was compared in the three mutant strains. The expected 2.1 kb gene disruption products were observed (lanes 12, 13 and 14) in
comparison to the 1.5 kb product from the wild-type hrpA gene (lane 11). Lane 15 was a negative control (c
2) that lacked DNA template. Panel 4)
Confirmation of the correct insertion site was performed using combinations of the target gene primers and primers internal to the gentamicin
cassette to amplify the hrpA boundaries. The left boundary in the hrpA knockout clones displayed the expected 1.4 kb product (lanes 18, 20 and 22)
and the right boundary showed the expected product of approximately 1.3 kb (lanes 19, 21 and 23). A 100 bp ladder on the left side of Fig. 1B is
relevant to the two left panels, and a 1 kb ladder on the right side applies to the two right panels (M). The schematic in part A of the figure is
modified from [13].
doi:10.1371/journal.pone.0022168.g002
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and outer surface protein A (OspA, BBA15) were identified twice
from different protein spots within one 2D gel, likely the result of
protein modification. EF-Tu (spots 9 and 23) displayed the same
migration in the isoelectric focusing dimension and ran with
molecular masses of approximately 59 and 45 kDa, respectively.
The 45 kDa spot corresponds to the full length protein and the
higher mass band likely represents a modified form without any
changes in pI. These two spots showed an estimated decrease of
8.27 and 2.62 fold in an hrpA background relative to wild-type.
Interestingly, the OspA protein (spots 10 and 32) showed both a
decrease of 6.81 (spot 10) and an increase of 8.01 fold (spot 32) in
hrpA mutant strains. These two spots displayed vastly different
migration in both dimensions, consistent with post-translational
modification. Of the 18 proteins identified by 2D gels coupled with
LC/MS-MS, 10 of these proteins were also identified by iTRAQ
analysis (marked with asterisks in Table 3). The highest fold
decrease (50.39) detected by 2D gels was from the large subunit of
the putative phage terminase (BBM42). This protein is encoded by
cp32-6, which was absent from one of the hrpA mutant clones used
in this study, thereby contributing to an artificially high decrease in
this protein relative to the wild-type strain. The average fold
decrease from the two strains carrying cp32-6 was 34, still
indicating a major change in expression.
iTRAQ proteome analysis for proteins differentially
expressed in wild-type and hrpA mutant B. burgdorferi
Analysis by 2D gels is time consuming, only semi-quantitative,
limited to analysis of single isoforms and requires gel spots that are
resolvable as stained unique species. In contrast, iTRAQ analysis
[39,40] is expedient, allows simultaneous analysis of hundreds of
proteins, is highly accurate, and captures data from all isoforms.
To follow-up on the 2D gel results, quantitative iTRAQ analysis
was performed on the hrpA mutant clones and the parental wild-
type strain. For the iTRAQ proteome analysis, the goal was to
create an experimental design that would allow control of
experimental and technical variations as much as possible.
Biological variation was controlled by pooling four independent
cultures for each sample. In this way, protein from 32 cultures was
analyzed in an 8-plex format. Protein extracts from the wild-type
and each of the three mutant strains were analyzed in duplicate,
where each of the eight samples was labeled with a different
isobaric tag to allow simultaneous processing. Trypsinized proteins
were analyzed and identified as described in Materials and
Methods. Through the iTRAQ analysis, 370 proteins were
identified (Table S2). Out of 370, 90 were significantly
(P,0.05) downregulated in the hrpA mutant strains relative to
the wild-type; 71 were encoded by the chromosome and 19 by
plasmids (Table S3). An even greater number (97) of upregulated
proteins were identified: 84 chromosomal and 13 plasmid-encoded
(Table S4).
The fold decrease of the downregulated proteins was between
1.20 and 14.28 in an hrpA background. The downregulated
proteins directly identified in this study were compared with genes
previously reported to be regulated at the transcriptional level by
microarray experiments [7,12,15,21,23,24]. Out of 90 downreg-
ulated proteins identified in this study (Table S3), the RNA for
four of them were reported as downregulated in an rrp2 mutant
while nine were upregulated in an rrp2 background [21,23]. In an
rpoN mutant background four of the 90 were downregulated, 14
were upregulated and one was inconsistently reported as both
down and up [7,21]. In an rpoS mutant eight were downregulated
and 10 were upregulated [7,12,21]. In an rrp1 mutant 17 were
downregulated and one was upregulated [24]. Finally, in a bosR
mutant [15], the transcripts of seven genes were upregulated and
none were downregulated. In summary, of the 90 proteins
downregulated in hrpA mutant clones, the transcription for 42 of
Table 1. Plasmids and strains used in this study.
Gene target Locus Description Plasmid E. coli strains gent polarity B. burgdorferi mutant strains
hrpA bb0827 RNA helicase pAD55 GCE1567 forward hrpA2 (GCB1164), hrpA3 (GCB1165), hrpA4
GCB1166)
bb0826 bb0826 hypothetical prot pPOH57-1 GCE2149 forward bb0826-11 (GCB544)
bb0826 bb0826 hypothetical prot pPOH57-2 GCE2150 reverse bb0826-3 (GCB543)
doi:10.1371/journal.pone.0022168.t001
Table 2. Effect of a mutation in the B. burgdorferi hrpA (bb0827) or bb0826 gene on infection of C3H/HeN mice.
B. burgdorferi
genotype Strain
Total
mice
a
Day 7
Blood
b
Day 7
Infection
Day 21
Ear
Day 21
Infection
Day 35
c
Heart
Day 35
c
Bladder
Day 35
c
Joint
Day 35
c
Ear
Total
sites
d
Day 35
Infection
B31 5A4 (wt) GCB933 18 18/18 100.0% 18/18 100.0% 4/4 4/4 4/4 4/4 16/16 100.0%
hrpA2 GCB1164 3 0/3 0.0% 0/3 0.0% 0/3 0/3 0/3 0/3 0/12 0.0%
hrpA3 GCB1165 3 0/3 0.0% 0/3 0.0% 0/3 0/3 0/3 0/3 0/12 0.0%
hrpA4 GCB1166 3 0/3 0.0% 0/3 0.0% 0/3 0/3 0/3 0/3 0/12 0.0%
bb0826-3 GCB543 2 2/2 100.0% 2/2 100.0% 2/2 2/2 2/2 2/2 8/8 100.0%
bb0826-11 GCB544 2 2/2 100.0% 2/2 100.0% 2/2 2/2 2/2 2/2 8/8 100.0%
aThere is a large number of mice in the control group because the hrpA mutants were initially assessed as part of a larger group of mutants.
bValues listed correspond to number of positive cultures/number of sites tested.
cFour mice infected with B. burgdorferi 5A4 were chosen as positive controls for organ harvests at day 35.
dNumber of positive tissue sites/number of sites tested.
doi:10.1371/journal.pone.0022168.t002
HrpA Is Involved in Global Gene Regulation
PLoS ONE | www.plosone.org 4 July 2011 | Volume 6 | Issue 7 | e22168them showed no detectable regulation by any of the known B.
burgdorferi regulators noted above.
The fold increase of the upregulated proteins was between 1.2
and 11.77 in an hrpA background. The upregulated proteins
directly identified in this study were compared with genes
previously reported to be regulated by microarray experiments
[7,12,15,21,23,24]. Out of 97 upregulated proteins identified in
this study (Table S4), five of them have been reported as
upregulated in an rrp2 mutant while seven are downregulated in
an rrp2 background [21,23]. In an rpoN mutant background nine of
the 97 were upregulated and 11 were downregulated [7,21]. In an
rpoS mutant, nine were upregulated and 11 were downregulated
[7,12,21,23,24]. In an rrp1 mutant there were no upregulated
proteins but eight were downregulated [24]. Finally, in a bosR
mutant [15], the transcripts of three genes were upregulated and
six were downregulated. In summary, of the 97 proteins
upregulated in hrpA mutant clones, the transcription for 65 of
them showed no detectable regulation by any of the known B.
burgdorferi regulators noted above.
Discussion
RNA regulation is a burgeoning field in bacteria in general
[41,42,43,44,45,46,47] and in the control of virulence in bacterial
pathogens [48,49]. RNA helicases are ubiquitous proteins that
play a role in a wide variety of RNA metabolic functions including
transcription, ribosome biogenesis, RNA unwinding, RNA-protein
complex disruption and reorganization, RNA processing and
RNA decay [30,31,32,33]. Based upon sequence analysis, B.
burgdorferi appears to have a single RNA helicase, the DEAH-box
protein HrpA (Fig. 1). In contrast, E. coli carries five DEAD-box
helicases [50] as well as an HrpA orthologue [50]. HrpA from
both E. coli [51] and B. burgdorferi (A. Salman-Dilgimen and G.
Chaconas, unpublished) display ATPase activity in vitro.A nin vitro
helicase activity has not yet been reported for either protein,
although the strong correspondence of the B. burgdorferi protein
sequence to the eight motifs of ATP-dependent RNA helicases
(Fig. 1) strongly supports assignment as an RNA helicase. Further
biochemical characterization of HrpA will be required to
conclusively establish an RNA helicase function.
During our studies on the proteins involved in antigenic
switching at the vlsE locus of B. burgdorferi [13] we found that
disruption of the hrpA gene resulted in complete loss of infectivity
of C3H/HeN mice by needle inoculation (Table 2). This result
was observed with three independent hrpA mutant clones,
suggesting that the hrpA gene disruption was responsible for the
phenotype, rather than some other defect introduced during
genetic manipulation. To prove this point a wild-type hrpA gene
with its native promoter (the topA promoter) was introduced into
the mutant clones on an E. coli – B. burgdorferi shuttle vector,
pBSV2 [38]. However, no restoration of infectivity was observed
(data not shown). Genetic complementation in B. burgdorferi can
sometimes be difficult to achieve. For example complementation
of ruvA and ruvB using shuttle vectors could not be achieved in two
independent laboratories [13,52]. The reason for this remains
unknown. We believe that the possibility of having a secondary
mutation with an identical phenotype in infectivity and protein
expression in all three of our clones is exceedingly low. We also
showed that the hrpA gene disruption is not polar (Fig. S2) and
that disruption of the downstream gene bb0826 resulted in a
completely infectious phenotype. From our combined data we
conclude that the hrpA gene is required for infectivity, at least by
needle inoculation and that HrpA is, therefore, a virulence
determinant [53].
Figure 3. Silver stained 2D gel images. Whole cell protein extracts are shown for A) wild-type B. burgdorferi B31 clone 5A4 [37] and B) hrpA
mutant strain GCB1165. Whole cell protein extracts were separated on non-linear pH 3–10 IPG strips in the first dimension and 12% SDS-PAGE gels in
the second dimension. Differentially expressed protein spots are circled and numbered. Select proteins were identified by trypsin digestion followed
by LC MS/MS analysis of spots from silver stained gels. Table S3 shows relative fold differences in expression.
doi:10.1371/journal.pone.0022168.g003
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analyzed the protein content of our three hrpA mutant clones
grown in culture, relative to the wild-type parent and found
indistinguishable patterns in the three mutant strains with an
obvious difference in protein expression relative to the wild-type
parent strain (Fig. 3 and Table 3). To more thoroughly and
quantitatively investigate the differences in protein expression in
the wild-type and mutant strains we performed a proteome
analysis using iTRAQ methodology [39,40]. We identified 370 B.
burgdorferi proteins, of which 187 showed significant changes in
expression compared to the wild-type parent: 90 were downreg-
ulated (Table S3) relative to wild-type and 97 were upregulated
(Table S4). When compared to the changes observed with
mutants in other regulatory systems, 42 of the 90 downregulated
proteins (Table S3) and 65 of the 97 upregulated proteins (Table
S4) are not regulated under any conditions by the previously
reported B. burgdorferi regulators bosR, rrp2, rpoN, rpoS or rrp1
[7,12,15,21,23,24].
Functional categorization of the regulated proteins relative to
the B. burgdorferi proteome (Fig. 4) revealed that the most
Table 3. Changes in protein expression in hrpA mutant clones relative to wild-type B. burgdorferi as estimated by 2D gel
electrophoresis.
Spot ORF Protein Name Decrease
1 BB_M42 Phage terminase, large sub, pbsx fam 50.39
2N A N A 41.31
3 BB_N43 Phage terminase, large sub, pbsx fam 40.38
4 BB_0831 Xylose operon reg prot (XyIR-2) 32.84
5* BB_0366 Vacuolar aminopeptidase I 32.62
6N A N A 31.64
7N A N A 22.64
8N A N A 11.58
9* BB_0476 Translation elong factor Tu 8.27
10 BB_A15 Outer surface protein A (OspA) 6.81
11 BB_J02.1 Conserved hypothetical protein 6.21
12 NA NA 6.02
13 NA NA 4.94
14 BB_0658 Phosphoglycerate mutase fam prot 4.79
15* BB_0215 ABC trans peripl PO4 bind prot (PstS) 4.24
16 BB_0239 Deoxyguan/deoxyadenosine kinase(Dck) 4.11
17 BB_0127 Ribosomal protein S1 (RpsA) 3.44
18 NA NA 3.30
19* BB_0540 Translation elong factor G 3.07
20 NA NA 3.00
21* BB_0020 PF6F1P b sub 2.84
22* BB_0463 Nucleoside- diphosph kinase (NDK) 2.67
23* BB_0476 Translation elong factor Tu 2.62
24* BB_0375 Pfs protein (Pfs-1) 2.58
25* BB_0513 Phe-tRNA ligase alpha chain (PheRS) 2.57
26 BB_0559 PTS system, gluce-spec IIA comp 2.48
27 NA NA 1.87
28 NA NA 1.71
29 NA NA 1.58
30 NA NA 1.53
31 NA NA 1.52
Spot ORF Protein Name Increase
32 BB_A15 Outer surface protein A (OspA) 8.01
33* BB_J09 Outer surface protein D (OspD) 1.66
Changes in protein expression in hrpA mutants relative to wild-type B. burgdorferi as determined by 2D gel electrophoresis. Average fold increase or decrease was
estimated as the mean value from two gels of the ratio between the spot volumes in wild-type Borrelia burgdorferi B31 and the hrpA mutant strains hrpA2 (GCB1164),
hrpA3 (GCB1165) and hrpA4 (GCB1166). Spot volumes were estimated using REDFIN 2D gel analysis software.
*indicates the proteins identified with both 2D gel and iTRAQ analysis.
NA indicates spots that were not identified. The 20 most abundant spots with a changed expression pattern in the mutants were identified by LC MS/MS analysis as
described in materials and methods.
doi:10.1371/journal.pone.0022168.t003
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cell envelope, hypothetical proteins and protein fate. In contrast,
the most prominent categories of upregulated proteins were
protein synthesis, cell envelope, unclassified, transcription and
protein fate, with protein synthesis representing 34% of the total.
From the sum of the data discussed above we conclude that HrpA-
mediated regulation is part of a new and distinct global regulatory
pathway in B. burgdorferi gene expression. Since our iTRAQ
analysis identified only a portion of the proteins in the total B.
burgdorferi proteome, we have almost certainly identified only a
subset of the HrpA-regulated B. burgdorferi proteins. Finally, it is
noteworthy that HrpA itself has been reported to be slightly
upregulated in an rpoN mutant [7].
B e c a u s ea nH r p Ao r t h o l o g u ei sp r e s e n ti nm a n yb a c t e r i a ,i t s
function in a global regulatory pathway in B. burgdorferi may have
relevance in other bacterial species where its function remains
obscure. The only known function of HrpA at thistimeis a single case
where regulation of the expression of a fimbrial gene in E. coli has
been reported [34]. Our work may, therefore, stimulate the
investigation of possible global regulation of gene expression by
HrpA in other bacteria. A role for an RNA helicase in global gene
regulation in bacteria is both new and particularly timely with the
recent growth of the field of RNA regulation of gene expression and
the ability ofRNA helicases to modulate RNA structureand function.
The reason why a complete loss of infectivity results from
disruption of hrpA remains to be established. A notable point is that
P66, which is required for infectivity, (Jenifer Coburn, personal
communication) is downregulated five fold in the hrpA mutant and
this may cause or contribute to the infectivity loss. In addition six
of the 11 oligopeptide permeases (OppA-1, OppA-2, OppA-3,
OppA-4, OppD and OppF) are all downregulated, which may
compromise the ability of the spirochetes to survive in a mouse.
Similarly, other transport systems were found to be downregulated
in the hrpA strains (see Table S3) as were the protein chaperones
GroEL and GroES. The inability to infect mice may result from a
combined effect of the downregulation of these and other proteins.
Alternatively, the upregulation of a variety proteins resulting from
loss of hrpA may also have deleterious consequences for survival in
the mouse. However, the experiments reported here have
analyzed changes in protein expression during growth in culture.
Therefore, we do not yet know the role of HrpA in the synthesis or
stability of proteins in the tick vector or vertebrate host. Further
studies will be required to assess the possibility of growing an hrpA
mutant in ticks and in DMCs for such analyses. Growth of an hrpA
mutant in ticks or DMCs would also aid further expression studies
to be performed under different conditions to more thoroughly
characterize the complete spectrum of HrpA regulated protein
expression during the enzootic cycle.
In terms of the mechanisms by which HrpA might both
upregulate and downregulate gene expression, it is too early to
speculate. In the one case where HrpA has been shown to regulate
fimbrial gene expression in E. coli, it is involved in the processing of
a polycistronic mRNA [34]. HrpA may function in global
regulation indirectly as a master regulator to turn on the
expression of one or more activators or to turn off the expression
of one or more repressors. We did not, however, uncover HrpA
regulation of any of the known B. burgdorferi regulators such as
BosR, Rrp2, RpoN, RpoS or Rrp1. Alternatively, HrpA might
function directly in transcription or post-transcriptional events (see
[30,31,32,33]) for a large number of genes. The abundance of
activities that can be modulated by RNA helicases, most of which
are at the post-transcriptional level, leaves many possible
mechanistic alternatives. Further studies on HrpA regulation in
vivo as well as protein function in vitro will help to elucidate the
mechanism of this fascinating protein, which may possibly hold a
general role in global regulation of gene expression in bacteria.
Materials and Methods
Ethics statement
This study was carried out in accordance with the principles
outlined in the most recent policies and Guide to the Care and Use of
Experimental Animals by The Canadian Council on Animal Care.
Our animal protocol (M08042) was approved by The Animal
Care Committee of the University of Calgary.
Bacterial strains and culture conditions
E. coli DH5a was used for the construction and maintenance of
the knockout plasmids. Infectious Borrelia burgdorferi B31 clone 5A4
[37] was used as the parental strain to generate the hrpA and
bb0826 mutants. All B. burgdorferi clones were cultivated at 35uC
(with a 1.5% CO2 environment) in BSK-II medium prepared in-
house [54] and supplemented with 6% rabbit serum (Cedarlane
Laboratories, Burlington, ON, Canada). To cultivate B. burgdorferi
from mouse tissues, 16 Borrelia antibiotic cocktail (20 mg/ml
phosphomycin, 50 mg/ml rifampicin and 2.5 mg/ml amphotericin
B) was added to the culture media. Bacterial density was
determined by dark-field microscopy using a Petroff-Hausser
chamber.
Gene disruption in B. burgdorferi
Disruption of hrpA and bb0826 was performed as previously
described [13]. Briefly, a 1.5 kb region containing the targeted
gene was amplified from B. burgdorferi B31 clone 5A4 DNA [37] by
PCR using target/f and target/r primers (see Table S1) and
cloned into either pJET1.2/Blunt (Fermentas) for hrpA or pCR-
BluntII-TOPO (Invitrogen) for bb0826. The central part of the
target gene was removed by inverse PCR using outward-oriented
primers containing a 59 NheI restriction site and replaced by a
gentamicin resistance cassette (aacC1) under the control of the flgB
promoter. For the bb0826 knockout plasmid, the gentamicin
resistance cassette was amplified from pBSV2g [55] using B415
and B416 primers containing 59 NheI restriction site. For the
disruption of the hrpA gene, the flgB promoter-driven gentamicin
resistance cassette was fused to a T7 transcriptional terminator (59
CTG CTA ACA AAG CCC GAA AGG AAG CTG AGT TGG CTG
CTG CCA CCG CTG AGC AAT AAC TAG CA TAA CCC CTT GGG
GCC TCT AAA CGG GTC TTG AGG GGT TTT TTG 39)b y
overlap extension PCR. Resistance to gentamicin was used as the
selectable marker. The orientation of the gentamicin resistance
cassette relatively to the target gene was determined by PCR using
either target/f or target/r primer, specific to the gene target, in
combination with either B348 or B349 for the hrpA disruption or in
combination with B348 or B1281 for the bb0826 knockout (See
Figure 2 and Table 1). To generate hrpA and bb0826 gene
disruptions, each knockout plasmid was used to transform
infectious B. burgdorferi B31 clone 5A4 strain by electroporation.
Gene disruption was confirmed by PCR and Southern blot
hybridization as previously described [13,56,57] and as described
in the Results section. Plasmid content was analyzed as previously
described [13] and three isolates were chosen for further analysis.
The three isolates were classified as independent clones based
upon subsequent transformability and plasmid content.
RT-PCR analysis for the downstream genes of hrpA;
bb0825 and bb0826
B. burgdorferi cultures were harvested by centrifugation when
they reached the concentration of ,1610
8 cells/ml in 10 ml
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Aurum Total RNA Mini Kit as per manufacturer’s instructions.
RNA concentrations were determined using a NanoDrop
spectrophotometer and the integrity of the RNA was assessed by
agarose gel electrophoresis. cDNA was generated for bb0825 and
bb0826 by The RevertAid H Minus First Strand cDNA Synthesis
Kit, Fermentas using gene specific primers (Table S1) according
to manufacturer’s instructions. For subsequent PCR reactions,
1 ml of cDNA was used as a template in 50 ml reactions with 10
pmoles of each primer. PCR reactions were run for 25, 30 and 35
cycles to ensure that saturation had not been reached.
Mouse infections
Three to four week old male C3H/HeN wild-type mice were
obtained from Harlan Laboratories or Charles River Laboratories
(St-Constant, QC). Mice were infected by intraperitoneal and
dorsal subcutaneous injection of 100 ml containing 1610
4
spirochetes/ml at each site. Infectivity and persistence of B.
burgdorferi in mice was determined as previously described [13]. A
50 ml blood sample was collected from the saphenous vein seven
days post-infection and cultivated as described above. At day 14
and 21, two ear punch biopsies were taken and cultivated for the
presence of spirochetes. The heart, ear, bladder and joint were
collected 35 days post-infection and cultivated. The presence of B.
burgdorferi in culture was determined by dark-field microscopy.
Protein sample preparation
For 2D gel electrophoresis wild-type B. burgdorferi B31 clone 5A4
[37] and the hrpA mutant strains GCB1164 (hrpA2), GCB1165
(hrpA3) and GCB1166 (hrpA4) were grown to late log phase
(,1610
8 cells/ml) in 100 ml BSK-II medium prepared in-house
and harvested by centrifugation (80006 g, 15 min, 4uC). Cell
pellets were washed twice with 50 ml of 50 mM Tris-HCl, pH 7.5
and centrifuged as above. The pellets were then suspended in lysis
buffer containing 25 mM Tris-Base, 50 mM KCl, 3 mM EDTA,
3 mM, benzamidine, 2.1 mM leupeptine, 9 M Urea, 2% ampho-
lyte 3–10, 1% TritonX-100, 70 mM DTT and protease inhibitor
cocktail (according to the manufacturer’s instructions, Sigma-
Aldrich, Cat No. P8465). The cells were lysed by 5 cycles of
freezing in liquid nitrogen and thawing at room temperature. The
soluble whole cell protein extracts were collected by centrifugation
at 50,0006 g at room temperature for 45 minutes. The samples
were then reduced by addition of tributylphosphine to 5 mM at
room temperature with an incubation of one hour with occasional
shaking. The samples were subsequently alkylated by addition of
iodoacetamide to 15 mM with an incubation of 1.5 hours at room
temperature in the dark.
For iTRAQ, samples were harvested and prepared as noted
above, with some modifications. For iTRAQ, DTT was not
included in the lysis buffer and the reduction and alkylation steps
were excluded from the sample preparation method. Samples
were then diluted with HPLC-grade H2O to a final concentration
of 4 M urea and then precipitated overnight with ice-cold acetone
at 220uC. Precipitated samples were collected by centrifugation at
8,0006ga t4 uC for 20 minutes and the pellets were dried at room
temparature for 30 minutes. Dried samples were submitted for
analysis at the University of Victoria Genome BC Proteomics
Center.
2D gel electrophoresis experiments and protein
identification
Protein concentrations were determined using the Bradford
protein assay [58] with BSA as a standard. For separation in the
first dimension by isoelectric focusing (IPG gels, GE Healthcare
Immobiline
TM DryStrip, pH 3–10 NL, 18 cm) samples (150 mg
for analytical and 250 mg for preparative gels) were applied on
strips allowing an overnight rehydration in buffer containing 8 M
urea, 2% (w/v) Triton X-100, 0.5% (v/v) ampholyte 3–10,
0.002% Bromophenol blue and 18 mM DTT. The strips were
focused using the IPGphor system (Amersham) with a gradient
voltage increase of 500 V for 1 hour, 1000 V for 8 hours, 8000 V
for 3 hours and a constant 8000 V for 2.5 hours. The focused
strips were stored at 280uC until the second dimensional run.
Prior to the second dimensional separation by 12% SDS PAGE,
the strips were equilibrated sequentially in two different buffers.
The strips were first incubated in equilibration buffer I containing
6 M urea, 75 mM Tris-HCl pH 8.8, 29% (v/v) glycerol, 2% SDS
(w/v), 0.002% bromophenol blue and 64 mM DTT with a gentle
shaking, for 15 minutes at room temperature. Following this, the
strips were incubated in equilibration buffer II containing 6 M
urea, 75 mM Tris-HCl pH 8.8, 29% (v/v) glycerol, 2% SDS (w/
v), 0.002% bromophenol blue and 135 mM iodoacetamide for a
further 15 minutes at room temperature with gentle shaking.
Second dimensional runs were standard 12% SDS-PAGE gels
(18 cm620 cm). The runs were started at 90 V for one hour,
followed by 160 V for one hour and 200 V for five hours.
Analytical 2D gels were silver stained [59,60] (Heukeshoven
method for analytical and Shevchenko method for preparative
gels) and analytical gels were dried under vacuum in a gel dryer.
Protein expression differences between wild-type B. burgdorferi B31
clone 5A4 and the hrpA mutant strains GCB1164, GCB1165 and
GCB1166 were compared to determine differential expression
using REDFIN 2D gel analysis software (Ludesi, Sweden). Protein
abundance changes of 1.5 or greater for the average of the three
mutant clones versus the wild-type were candidates for differen-
tially expressed proteins and were circled and numbered in Fig. 3.
Some of these spots were cut out from silver stained preparative
gels for in-gel tryptic digestion and subsequent identification by
LC- MS/MS at Southern Alberta Mass Spectrometry (SAMS)
Centre for Proteomics, a Core Facility of the University of
Calgary, Faculty of Medicine using a MASCOT (Matrix science
Ltd., London United Kingdom, www.matrixscience.com) data-
base search. For in-gel tryptic digestion, briefly, protein spots were
cut out from preparative silver stained gels with a scalpel, minced
into one mm
3 pieces and transferred to pre-washed (60%
Acetonitrile/0.1% TFA) microcentrifuge tubes. Spots were
washed two times with HPLC-grade H2O for 10 minutes and
then with freshly made destaining solution containing 30 mM
K3Fe(CN)6 and 100 mM Na2S2O3, 2 times for eight minutes at
room temperature. After destaining a second H2O wash was
performed. Excessive washing and short periodic low speed
vortexing were done when necessary till all the stain was removed.
Following this, dehydration of the gel pieces was performed with
an incubation in 100% acetonitrile for 10 minutes at room
temperature. All the acetonitrile was then removed and opaque gel
pieces were air-dried at room temperature and then rehydrated for
60 minutes at 4uC in 20–50 ml of trypsin working solution (50 mM
Figure 4. Pie chart representations for functional categorization of B. burgdorferi B31 proteins. A) The whole genome B.burgdorferi pie
chart was created using data from The Comprehensive Microbial Resource database (http://cmr.jcvi.org/cgi-bin/CMR/shared/GetNumAndPercent
GenesInARole.cgi). B) The pie chart showing proteins downregulated (total 90 proteins) in hrpA mutant clones was created using the data in Table
S3. C) The pie chart showing proteins upregulated (total 97 proteins) in hrpA mutant clones was created using the data in Table S4.
doi:10.1371/journal.pone.0022168.g004
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20 ng/ml trypsin, Princeton Separations, porcine, sequencing
grade, modified). Samples were then incubated at 37uC overnight.
The next day 1/5 volume 5% TFA was added to the samples
followed by incubation at 60uC for 1 hour. Digested samples were
then cleaned up using Zip Tips C18 (Millipore) and eluted with
10 ml elution solution (85% acetonitrile, 0.1% TFA). Eluted
samples were stored at 220uC for further LC MS/MS analysis.
iTRAQ experimental design and analysis
The iTRAQ analysis was designed as an 8-plex experiment
enabling two comparisons of wild-type B. burgdorferi to three separate
hrpA mutant clones. To control for biological variation, 8 individual
samples (B31-1, B31-2, 1164-1, 1164-2, 1165-1, 1165-2, 1166-1, and
1166-2) were prepared by pooling four independent cultures for each.
Technical and experimental variations were controlled by having
replicate samples (e.g. B31-1 and B31-2) digested separately and
tagged with different isobaric tags in the 8-plex iTRAQ experiment.
Total protein extracts were submitted to the University of
Victoria-Genome BC Proteomics Centre for iTRAQ analysis.
Briefly, samples were reduced with TCEP (Tris[2-carboxyethyl]
phosphine) and alkylated with MMTS (s-methyl thiomethanesul-
fonate). Proteins were then digested in solution with trypsin
(Promega) and labeled with appropriate iTRAQ labels. Isobaric
labels assigned to individual samples were as follows; B31-1/113,
1164-1/114, 1165-1/115, 1166-1/116, B31-2/117, 1164-2/118,
1165-2/119, 1166-2/121. The labeled peptides were combined
and separated by strong cation exchange HPLC. Fractions were
then analyzed by LC-MS/MS.
LC-MS/MS
LC-MS/MS analysis was performed using an integrated Famos
autosampler, Switchos II switching pump, and UltiMate micro
pump (LC Packings, Amsterdam) system with an Hybrid
Quadrupole-TOF LC/MS/MS Mass Spectrometer (QStar Pulsar
i) equipped with a nano-electrospray ionization source (Proxeon,
Odense, Denmark) and fitted with a 10 mm fused-silica emitter tip
(New Objective, Woburn, MA). Chromatographic separation was
achieved on a 75 mm615 cm C18 PepMap Nano LC column and
a 300 mm65 mm C18 PepMap guard column was in place before
switching inline with the analytical column and the MS. The
mobile phase (solvent A) consisted of water/acetonitrile (98:2 (v/v))
with 0.05% formic acid for sample injection and equilibration on
the guard column at a flow rate of 100 ml/min. A linear gradient
was created by mixing solvent A with solvent B that consisted of
acetonitrile/water (98:2 (v/v)) with 0.05% formic acid at a reduced
flow rate of 200 nl/min for high resolution chromatography and
introduction to mass spectrometer.
Samples were brought up to 100 ml with 5% acetonitrile and
3% formic acid and transferred to autosampler vials (LC Packings,
Amsterdam). 20 ml of sample were injected in 95% solvent A and
allowed to equilibrate on the trapping column for 10 mins. Upon
switching inline with the MS, a linear gradient from 95% to 40%
solvent A was developed for 100 minutes and in the following
5 minutes the composition of the mobile phase was decreased to
20% solvent A before increasing to 95% solvent A for a 15 minute
column re-equilibration prior to the next sample injection.
MS data was acquired automatically using Analyst QS 1.0
software Service Pack 8 (ABI MSD SCIEX, Concord, Canada).
An information dependent acquisition method consisting of a
1 second TOFMS survey scan of mass range 400–1200 amu and
two 2.5 second product ion scans of mass range 100–1500 amu.
The two most intense peaks over 20 counts, with charge state 2–5
were selected for fragmentation and a 6 amu window was used to
prevent the peaks from the same isotopic cluster from being
fragmented again. Once an ion was selected for MS/MS
fragmentation it was put on an exclude list for 180 seconds.
Curtain gas was set at 23, nitrogen was used as the collision gas
and the ionization tip voltage used was 2700 V.
All data files were searched for protein identification and
relative abundance using Protein Pilot (V.3.0) and were searched
against a custom B. burgdorferi B31 database. A positive protein
identification required at least two matching peptide sequences
with a minimum of a 95% confidence limit in ProtScore.
iTRAQ ratios were expressed as mutant/wild-type, using wild-
type B31-1 and B31-2 samples (isobaric labels 113 and 117,
respectively) as denominators in Protein Pilot software. Finally, the
12 iTRAQ ratios obtained (see Table S2) were used for
subsequent data analysis. After transferring all data sets from
Protein Pilot to Microsoft Excel, iTRAQ values were ranked
according to the mean values calculated from 12 individual ratios.
P values were calculated based upon the means of the 12 input
ratios using a two-sided, one sample t-test with comparison against
a theoretical value of 1.0 using GraphPad Instat (V.3.10). iTRAQ
ratios $1.2 or #0.8 were considered as being differentially
expressed if the P values were #0.05. Downregulated and
upregulated proteins were grouped separately in Table S3 and
Table S4, respectively. The total list of iTRAQ-identified
proteins is shown in Table S2.
Supporting Information
Figure S1 Gene disruption and the absence of addition-
al copies of the hrpA gene was confirmed by Southern
hybridization. Genomic DNA was digested with HindIII and
run on a 1.0% agarose gel with a 1 kb molecular weight ladder
(M). Probes complementary to the gentamicin (gent) resistance
cassette (left panel) and the portion of the hrpA gene deleted during
gene disruption (right panel) were used for hybridization to
duplicate blots. As expected, hybridization to the gent probe was
not observed in the wild-type strain but was observed at the
expected size (7.1 kb) for the three hrpA mutant strains.
Conversely, hybridization to the deleted portion of hrpA was
observed in the expected 6.5 kb fragment in the wild-type strain
but not in the three hrpA mutant clones.
(EPS)
Figure S2 Region view and transcription patterns of
hrpA, bb0825 and bb0826.A ) Schematic representation of hrpA
and the two downstream genes on the B. burgdorferi chromosome.
Arrows represent the direction of transcription and the numbers
denote the coordinates on the chromosome. B) Ethidium bromide
stained 1.4% agarose gel showing the products of RT-PCR
reactions to assess the transcription patterns of genes bb0825 and
bb0826 in the three hrpA mutant clones, along with a 100 bp
molecular weight ladder (M). Panel 1) RT-PCR reactions for
bb0825 in the wild-type parent strain (B. burgdorferi B31, clone 5A4)
and in the mutants hrpA2, 3 and 4. The expected product size was
210 bp. Panel 2) RT-PCR reactions for bb0826 in the strains
described in Panel 1. The expected product was 310 bp.
(EPS)
Table S1 Primers used in this study.
(PDF)
Table S2 Complete listing of iTRAQ results.
(PDF)
Table S3 Downregulated B. burgdorferi proteins in hrpA mutant
clones compared to wild-type based upon iTRAQ analysis.
(PDF)
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